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Background. Infertility is both a clinical and a public problem, aﬀecting the life of the couple, the healthcare services, and
social environment. Standard semen analysis is the surrogate measure of male fertility in clinical practice. Objective.T op r o v i d e
informationabouttherelationshipbetweensemenparametersandspontaneousconception.Methods.Weevaluatedretrospectively
453 pregnancies that occurred among 2935 infertile couples evaluated at an infertility clinic of a tertiary-care university hospital,
between 2004 and 2009. Results. Normal semen analysis was present only in 158 patients; 295 subfertile patients showed alterations
in at least one seminal parameter. A reduction in all seminal parameters was observed in 41 patients. Etiological causes of male
infertility were identiﬁed in 314 patients. Conclusion. Our data highlights the possibility of a spontaneous conception with semen
parameters below WHO reference values. Therefore, we support the importance of deﬁning reference values on a population of
fertile men. Finally, we analyzed the related ethical issues.
1.Introduction
Infertility is a common clinical problem. It aﬀects 13% to
15% of the couples worldwide [1]. In addition, infertility is
c o n s i d e r e da l s oap u b l i cp r o b l e m .I td o e sn o to n l ya ﬀect the
couples’ life, but it aﬀects the healthcare services and social
environment [2] .Am a l ef a c t o ri ss o l e l yr e s p o n s i b l ei na b o u t
20% of infertile couples and contributory in another 30–
40% [3]. If a male infertility factor is present, it is almost
always deﬁned by the ﬁnding of an abnormal semen analysis.
Clinicians usually rely on the results of semen analysis for
the assessment of male fertility. Standard semen analysis is
widely considered to be part of the routine assessment in
evaluating male fertility and the surrogate measure of male
fecundity in clinical practice [4, 5].
There is little consensus as to which parameter within a
conventional semen analysis is the best predictor of male fer-
tility. A correlation between sperm count and pregnancy has
been reported in previous studies [6–8], showing evidence of
a predictive value of sperm count. Therefore, WHO adopted
the threshold of 20 × 106/mL as reference for minimal value
of sperm count [9]. Routine semen analysis also includes the
evaluation of sperm morphology and motility; both of these
parameters are considered to be related to male fertility [6–
8, 10, 11].
However, since WHO reference values were adopted, it
has become evident that a basic semen analysis is insuﬃcient
to determine the fertility status of the male since previous
WHO reference values were made considering a “normal
population” of healthy men, and not a population of men
with proven fertility [12]. Due to this, serious concerns are
raised about the possibility of conceiving with semen param-
eters below WHO cutoﬀ values [7, 13, 14].
Additional sperm function tests, such as swelling and/or
eosine test, do not provide further information to traditional
semen parameters in the assessment of the fertility status of
infertile male patients [15].2 International Journal of Endocrinology
It is very diﬃcult to identify a semen parameter and/or
testcapableinitselfofpredictingmalefertility.Thisdiﬃculty
can lead to inaccurate diagnosis, inappropriate treatment,
and unnecessary anxiety on the part of the patient [10].
Therefore, a correct interpretation of male subfertility could
reduce the number of patients requiring assisted reproduc-
tion [16].
The role of the female partner must also be considered
in the assessment of potential male fertility. Minor degrees
of fertility impairment are not necessarily associated with
couple infertility when present in only one partner, because
the fertility status of the woman may compensate for the
partner’s subfertility [12].
We report a large retrospective study in a population of
infertile couples who conceived after aetiological therapies.
This study provides additional information regarding the
relationship between semen parameters and spontaneous
conception and regarding the indication for etiological treat-
ments also in presence of severe reduction in semen parame-
ters.
2.MaterialsandMethods
2935 infertile couples were evaluated at the infertility clinic
of a tertiary-care university hospital [“A. Gemelli” University
General Hospital, Rome (Italy)] between January 2004 and
June 2009. All these couples were unable to conceive for at
least 12 months. Each couple underwent evaluation by gy-
naecologists with expertise in infertility, supported by an-
drologists and endocrinologists. Physical examination, hor-
monal assessment of ovulatory function, screening for cervi-
calandvaginalinfections,transvaginalsonogram,evaluation
of tubal patency, and genetic assessment (when indicated)
were carried out in the female patients.
The male patients underwent physical examination. Ge-
netic assessment, endocrine factor, nonendocrine testicular
dysfunction, and accessory gland infections were also eval-
uated. Standard semen analysis was performed periodically
(every two months) in trusted laboratories, according to
WHO guidelines [9]. Etiological treatments were performed
in men that showed identiﬁed causes of infertility, whereas
empirical treatments (such as gonadotropins, antioxidants,
carnitine, and aspartic acid) were performed in men with no
identiﬁed causes of infertility.
Assisted reproductive techniques were not performed,
accordingtotheethicalguidelinesofourinstitution.Allcou-
ples expressed informed consent to this protocol.
453 couples obtained a spontaneous pregnancy. Clinical
and laboratory data, including standard semen analysis, were
collected from all couples. Semen parameters, obtained by
semen analysis within 60 days before the cycle prior to
conception, were evaluated in order to deﬁne seminal status
at conception. Recent studies demonstrated that the intrain-
dividual variation in seminal parameters has no clinical
value and that there is no indication that intraindividual
variation in semen parameters is more pronounced among
men from infertile couples when compared with healthy
controls[17].Therefore,oneejaculateisasuﬃcientindicator
of semen quality in a group of patients [18]. Semen analysis
Table 1: Time from the ﬁrst evaluation to the conception.
N o .o fm o n t h s N o .o fp a t i e n t s %o fa l lt h ep r e g n a n c i e s
12 187 41.3
24 187 41.3
36 54 11.8
48 25 5.6
Table 2: Causes of male infertility.
Cause No. of patients %o fa l lt h e
pregnancies
Male tract infections 168 37
Varicocele 113 25
Hormonal disfunction
(hypogonadism,
dysthyroidism, pituitary
disfunction)
72 16
Idiopathic infertility 100 22
was classiﬁed according to WHO reference values. Patients
were divided in diﬀerent groups according to sperm count,
motility, and morphology. Subsequently, we classiﬁed them
in diﬀerent groups according to the predictor value for preg-
nancies, as previously reported (oligospermia, asthenosper-
mia, teratospermia, and oligoasthenoteratospermia) [1–5,
7]. Patients with a reduction in sperm count were also
classiﬁed into 3 subgroups: severe (<5mil/mL), moderate
(5–15mil/mL), and mild (15–20mil/mL) oligospermia. For
each group, we evaluated the mean ± SD of seminal
parameters. In order to deﬁne the role of treatment in male
subfertility,wealsoevaluatedspermparametersatadmission
andafterthetherapies,thelastcarriedoutbeforeconception,
in the group with oligoasthenoteratospermia (OAT).
3. Results
The average age of the male population was (mean ± SD)
36.05 ± 5.73yrs, and of the female population was 33.62 ±
4.65yrs, in the 453 couples that conceived. The mean
duration of infertility was 29.08 ± 15.21 months. All the
pregnancies occurred within 48 months after the ﬁrst
evaluation at our institute (Table 1). Known causes of male
infertility were identiﬁed in 314 patients (69% of the preg-
nancies) (Table 2). Two causes of infertility were present
simultaneously in 39 patients.
Amongst genital tract infections, Ureaplasma urealyti-
cum, Mycoplasma hominis, and Gram-negative bacteria were
themostrecurrent(80%ofthespeciesidentiﬁed).Varicocele
waspresentin115patients(25%ofpatients),and52patients
underwent varicocele repair (surgical varicocelectomy or
scleroembolization).
Normal semen analysis was present only in 35% of
patients (158pts), with sperm count 74.93±40.16×106/mL,
linear motility 63.18 ± 12.51%, and normal morphology
53.74 ± 20.41%. 295 subfertile patients (65%) showed
alterations in at least one seminal parameter, as reported in
Figure 1.International Journal of Endocrinology 3
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Figure 1: Classiﬁcation of patients according to WHO reference
parameters [9].
A sperm count lower than WHO reference values, iso-
lated or associated with motility or morphology alterations,
was present in 116 patients (26% of the total pregnancies).
Sperm count in this group was 9.09 ± 4.9 × 106/mL. When
stratiﬁed according to the grade of oligospermia, 13 patients
presentedmild oligospermia, 71 hadmoderate oligospermia,
and 32 presented severe oligospermia (Table 3).
Isolated asthenospermia was the most frequent semen
abnormality and was present in 123 patients (27% of the
total pregnancies). Semen parameters in the asthenospermic
groupwerespermcount61.23±34.79×106/mL,linearmotil-
ity 33.09±11.25%, and normal morphology 55.51±20.40%.
Isolated teratospermia was present in 19 patients (4% of
the total pregnancies) and was associated with other seminal
alterations in 80 patients (18% of the total pregnancies).
Normal sperm morphology in isolated teratospermia was
22.29±2.22%,andinassociatedteratospermia,itwas15.28±
10.40%.
41 pregnancies were obtained by men with OAT (9%
of the total pregnancies). Sperm count in OAT group was
8.93 ± 5.12 × 106/mL, linear motility was 24.36 ± 12.67%,
and normal morphology was 13.00 ± 8.38%. In the OAT
group, aethiological causes of male infertility were identiﬁed,
isolatedorassociated,andtreatedin31patients.Malegenital
infections were appropriately treated in 28 patients, whereas
hormonal disfunctions involving dysthyroidism, hypogo-
nadism, and pituitary disfunctions were treated in 8 patients.
Varicocele was treated in 3 patients.
When comparing seminal analysis before and after aethi-
ological therapies in the OAT group, an increase in sperm
count was observed in 3 patients, while an increase in linear
motility was present in 15 patients. In 10 patients with idio-
pathic OAT, empirically diﬀerent kinds of pharmacological
treatments were tried: hMG/hCG, antioxidants, carnitine,
and aspartic acid. An increase in linear motility was observed
in 3 patients.
In the group of 52 patients who underwent varicocele
repair, sperm count (mean ± S D )a ta d m i s s i o nw a s9 .06 ±
4.34×106/mL,linearmotilitywas21.13±7.12%,andnormal
morphology was 18.74±3.93%. Semen analysis after surgery
in the varicocele group showed a signiﬁcative increase in
sperm concentration (14.24 ± 3.12 × 106/mL) and nor-
mal morphology (22.62 ± 3.05%) while a nonsigniﬁcative
increase was observed in sperm motility (25.31 ±8.27%).
4. Discussion
4.1. Altered Semen Parameters and Spontaneous Conception.
Subfertility is a common condition aﬀecting at least 15%
of couples during their reproductive lives, and in half of
these, a male factor is involved [1]. Recent evidence has
questionedtheclinicalvalueofWHOcriteriaforbasicsemen
analysis in the prediction of fecundity [8]. We report 453
pregnancies which occurred between January 2004 and June
2009 among 2935 infertile couples evaluated at our institute.
In the infertile couples, we applied a standard protocol
in terms of investigation and therapeutical management of
couples aﬀected by infertility, performed in both partners
in a sequential and parallel way. This was achieved by a
uniﬁed clinical management of the couple, which includes
gynecologists, endocrinologists, and andrologists, with spe-
ciﬁc interest in the ﬁeld of human reproduction.
Our data supports the possibility of spontaneous con-
ception with semen parameters below the WHO reference
values, as documented by the 65% of pregnancies that
occurred in our center. A sperm count reduction was, in
fact, observed in 116 patients (26% of the total pregnancies).
32 patients (27%) within the oligospermic group presented
severe oligospermia showing a sperm count of 3.58 ± 1.54 ×
106/mL. An overlap between fertile and infertile patients
in sperm concentration was previously reported [4, 6, 7].
Even though Bonde reported a predictive value for sperm
concentration with increase up to 40 × 106/mL [8], we
present a group of severe oligospermic men in couples
who conceived spontaneously. Astenospermia was the most
frequentsemenabnormality,bothwhenevaluatedasisolated
or associated with other semen abnormalities. This high
incidence is probably due to the high infection rate in
our patients [19]. Previous studies on sperm motility as
a predictor of infertility have proven contradictory [4, 6,
10, 11, 20]. This data seems to indicate that astenospermia
may be a surmountable condition in infertile couples. A
predictive value for normal morphology was previously
reported [4, 6, 7, 10, 20] although only moderate predictive
value for spontaneous pregnancy can be given. Conceptions
were in fact reported by men with teratospermia [7]. Our
data underscore the possibility of spontaneous conception
also with reduction in normal sperm morphology. When
we consider the percentage of normal morphology, it was
near the lower end of reference values (22% for isolated
teratospermia and 15% for associated teratospermia). Con-
ception did not occur with normal morphology <5%. As a
consequence, a conception with severe teratospermia might
be improbable; therefore, we conﬁrm that morphology
could be considered the best predictive parameter for male
fertility. We reported 41 pregnancies which occurred in men
aﬀected by oligoastenoteratospermia, even though Bonde
and Ombelet described an increase in predictive value when
altered seminal parameters were considered in combination
with each other [7, 8]. These data highlight that seminal4 International Journal of Endocrinology
Table 3: Stratiﬁcation of the patients with reduction in sperm count according to the grade of oligospermia.
Grade of oligospermia (sperm count range) Number of patients Sperm count (mean ± SD)
Mild (16–20 ×106/mL) 13 18,18 ±0,46 ×106/mL
Moderate (5–15 ×106/mL) 71 10,00 ±2,95 ×106/mL
Severe (<5 ×106/mL) 32 3,58 ±1,54 ×106/mL
parameters, even when considered together as a whole,
cannot exclude the possibility of a spontaneous conception.
For these reasons, we sustain that semen parameters cannot
leadtoaclear-cutdiscriminationbetweenfertileandinfertile
men.
4.2. WHO Reference Values for Seminal Parameters: What
Is “Normality”? Our data call into question the predictive
value of WHO reference values as a diagnostic test, which
are not always predictive of fertility. The WHO reference
values[9]weredrawnupconsideringapopulationofhealthy
men, disregarding the absolute minimal values of the semen
parameter necessary in order for conception to occur. As a
consequence, none of these parameters, considered alone or
in combination, can be considered diagnostic of infertility
[12]. In order to improve the clinical value of seminal
parameters, WHO recently revised its laboratory manual for
the examination and processing of human semen [21]. In
this edition, the lower reference limit for seminal parameters
is given at the 5th percentile in a population of men in
couples who conceived within 12 months. The new WHO
manual, considering as “normal population” the male of
proven fertility, reduces previous reference values and is in
agreement with our evidence of spontaneous conception
by men with reduced seminal parameters. To date, there
is no threshold in semen parameters which detects and
predicts male fertility. New molecular insights into sperm
properties which make it capable of fertilizing the egg are
recently emerging. Increased knowledge of sperm proteome
will allow us to have new predictors of molecular index in
male fertility [22].
4.3. Etiological Treatments for Male Infertility: Waste of Time
or Mandatory Practice? According to medical literature, 30–
40% of patients do not receive care based on available
scientiﬁc evidence [23]. On top of this, an estimated 20–
25% of provided health care is unnecessary [24]. In the case
of subfertility, this could mean the use of unnecessary and
expensive diagnostic tests and assisted reproductive tech-
niques(ARTs)[25].Itisdebatedhowlongpatientsshouldbe
treatedwithmedicalandsurgicaltherapies,strictlyaccording
to current clinical guidelines, when they present a signiﬁ-
cant range of uncertainty currently due to an incomplete
understanding of etiology and physiopathology of a clinical
condition.
Hughes et al. reported in a multicenter randomized trial
signiﬁcantly higher live birth rates per in vitro fertilization
(IVF)/intracytoplasmatic sperm injection (ICSI) cycle when
compared with no treatments for three months in women
with Fallopian tube patency [26].
Another trial compared the eﬀectiveness of immediate
IVF with six-month delayed IVF in couples with all causes of
infertility.Patientsinthetreatmentgroupreceiveduptofour
cycles of IVF treatment. Patients in the control group were
permitted to have any form of fertility treatment other than
IVF. Signiﬁcant diﬀerences were observed in pregnancy rates
percouple(17%withimmediateIVFversus8%withdelayed
IVF) and live birth rates per couple (12% with immediate
IVF versus 5% with delayed IVF). No details of the fertility
treatment received by the control group were presented [27].
A further randomized trial compared early IVF with late IVF
(after six months) in couples with all causes of infertility.
Patients in the treatment group received one cycle of
IVF treatment. The control group received other fertility
treatmentsduringthesix-monthwaitingperiod.Intentionto
treat analysis of all causes of infertility showed no signiﬁcant
diﬀerences in clinical pregnancy rates per couple (10% with
immediateIVFversus7%withdelayedIVF),norinlivebirth
rates per couple (9% with immediate IVF versus 5% with
delayed IVF).
According to these evidences, UK-NHS National Insti-
tute for Health and Clinical Excellence (NICE) Clinical Prac-
tise Guidelines (CPGs) for fertility assessment and treatment
for people with fertility problems (2004) [28] reported that
“the decision to recommend IVF treatment should take into
considerationthelikelihoodofspontaneouspregnancywith-
out treatment, in particular in cases where signiﬁcant spon-
taneouspregnancyratesmaybeexpected.”Asaconsequence,
accordingtotheseCPGs,severealterationsinseminalplasma
might be addressed immediately to IVF treatments.
In this paper, we report a conception in 453 couples
with infertility, treated with only medical and surgical ther-
apies; some of these presented severe alterations in seminal
parameters. The mild improvement of seminal parameters
in 18/31 patients aﬀected by severe combined alterations
in sperm count, motility, and morphology, via etiological
treatments, suggests that no patient should be excluded from
a complete diagnostic evaluation and etiological therapeutic
opportunity, even in presence of severe alterations in seminal
parameters.Therefore,thesigniﬁcantimprovementinsperm
concentration and morphology in selected patients who
underwent varicocele repair underlines that varicocele repair
may represent an eﬀective option to the fertility.
To date, unique CPGs have not yet been developed
regarding the indication and the timing for IVF techniques
in relation to seminal parameters. These data should be
therefore taken into consideration in evaluating current
CPGs for couple infertility.
4.4. Clinical Epistemology and Ethics Issues Considerations.
The present analysis raises two levels of considerations: the
epistemology of the CPG in male infertility/subfertility treat-
ment and the ethical issues related to this matter.International Journal of Endocrinology 5
It is well known that the CPGs are a set of recommen-
dationsbasedonevidenceasmuchaspossible,abletochange
the behavior in speciﬁc clinical scenarios [29]. Particularly,
the literature about male infertility shows that few clinical
trials with pregnancy as the main outcome measure have
been published. Consequently, WHO-CPG for male infertil-
ityarelimitedandinthisareaclinicalpracticeismerelydom-
inated by “authority-based” guidelines, even though WHO
reference clinical parameters are the most widely used crite-
ria to deﬁne a “male factor” [21].
Therefore, some points to be taken into consideration
with regard to ethical issues concerned in male infertility
treatment are as follows.
Firstly, the actual uncertainty of CPG on male infertility
treatment (MIT): it is ethically correct to reach the infertile/
subfertile patient/couple’s best interest not in one-way only,
that is, through the automatic shift towards ART, but also
utilizing other convenient remedies, according to a clinical
logic of “graduality” since it is sometimes possible to con-
ceive a baby without recurring to ART.
Secondly, the dutifulness of an adequate counselling
setting: In fact, the more recent literature [30–32] shows the
need for psychological and ethical counselling for infertile/
subfertile (naive and treated) couples. This data is also con-
ﬁrmed in ART legislation of many countries. For instance,
in Italy the speciﬁc law no. 40/2004 supplies the couple with
realistic information to face all the issues involved (beneﬁts,
risks,costs,clinicalalternatives,andpsycho-social/emotional
aspects), ethical issues enclosed, because it is strictly linked
to both patients’ personal values/preferences and physicians’
personal/professional values. At this condition, it would be
possible to create and safeguard an adequate relationship,
and we could contribute in increasing the autonomy of
patient’s mature and responsible choices, without leaving
him/her alone.
Thirdly, the need for a further development of alternative
remedies to solve/overcome fertility problems other than
ART [32].
Finally, the ethical reﬂection on MIT—also pursued
through an appropriate use of clinical ethics committees
[33]—could contribute to give meaning to objective limita-
tions of CPG, granting further value to the human subject.
This is one more reason to not immediately address the choi-
ces towards ART, without ﬁrst considering the relevant issues
on distributive justice, fairness, and prioritization criteria of
such expensive procedures [34–36].
5. Conclusions
The role of the endocrinologist/andrologist is primary and
necessary for a complete diagnostic evaluation and etiolog-
ical therapeutic opportunity, as reported in a large series of
pregnancies achieved in a single tertiary-care center expe-
rience. We conﬁrmed previous data about the impossibility
for semen parameters to lead to a clear-cut discrimination
between fertile and infertile men. As a consequence, no
patient should be automatically shifted towards ART, even
in presence of severe alterations in seminal parameters. ART
techniques should be considered after a suﬃcient time of
etiological therapies, also according to ethical criteria of
distributive justice, fairness, and prioritization.
Therefore, unique CPGs have not yet been developed
regardingtheindicationandthetimingforIVFtechniquesin
relation to seminal parameters. These data should be there-
fore taken into consideration in evaluating current CPG for
couple infertility.
In this context, new molecular insights about sperm
function in fertilizing the egg are recently emerging. Further
studies are therefore needed in this topic in order to identify
new molecular predictors of male fertility, which might solve
this ancient dilemma about clinical decision in male infertil-
ity.
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